Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $56.36B.
ENTERPRISE VALUE (EV)
$56.36B
Teva Pharmaceutical Industries Limited
Market Cap
$42.82B
Enterprise Value (EV)
$56.36B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Teva Pharmaceutical Industries Limited (TEVA) | $42.82B | $56.36B |
| IQVIA Holdings Inc. (IQV)vs › | $43.21B | $57.28B |
| Agilent Technologies, Inc. (A)vs › | $43.41B | $46.73B |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.56B | $44.25B |
| Humana Inc. (HUM)vs › | $47.04B | $54.74B |
| Alcon Inc. (ALC)vs › | $34.91B | $39.17B |
| ResMed Inc. (RMD)vs › | $34.72B | $33.57B |
| DexCom, Inc. (DXCM)vs › | $34.11B | $33.99B |
| Edwards Lifesciences Corporation (EW)vs › | $51.93B | $49.59B |
| Becton, Dickinson and Company (BDX)vs › | $52.22B | $67.94B |
Market Cap
$42.82B
Total Debt
$17.09B
Cash
$3.56B
Enterprise Value
$56.36B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
